Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Pathological evaluation and quality of surgery in radical cystectomy in New South Wales, Australia.

Ahmadi N, Delprado WJ, Brooks AJ, Brenner PC, Coombes GM, Grant A, Patel MI.

ANZ J Surg. 2015 Mar;85(3):145-9. doi: 10.1111/ans.12383. Epub 2014 Nov 19.

PMID:
25410154
2.

A novel method of bladder neck imbrication to improve early urinary continence following robotic-assisted radical prostatectomy.

Beattie K, Symons J, Chopra S, Yuen C, Savdie R, Thanigasalam R, Haynes AM, Matthews J, Brenner PC, Rasiah K, Sutherland RL, Stricker PD.

J Robot Surg. 2013 Jun;7(2):193-9. doi: 10.1007/s11701-012-0371-2. Epub 2012 Jul 26.

PMID:
27000912
3.

Cancer identified incidentally in the prostate following radical cystoprostatectomy: an Australian study.

Ahmadi N, Delprado WJ, Brooks AJ, Brenner PC, Coombes GM, Grant A, Patel MI.

ANZ J Surg. 2014 Jun;84(6):473-6. doi: 10.1111/ans.12015. Epub 2012 Dec 10.

PMID:
23216652
4.

Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha.

Yang JL, Qu XJ, Hayes VM, Brenner PC, Russell PJ, Goldstein D.

BJU Int. 2007 Jun;99(6):1539-45. Epub 2007 Mar 6.

5.

Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis.

Rasiah KK, Kench JG, Gardiner-Garden M, Biankin AV, Golovsky D, Brenner PC, Kooner R, O'neill GF, Turner JJ, Delprado W, Lee CS, Brown DA, Breit SN, Grygiel JJ, Horvath LG, Stricker PD, Sutherland RL, Henshall SM.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):711-6.

6.

Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.

Horvath LG, Henshall SM, Lee CS, Kench JG, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL.

Int J Cancer. 2005 Jan 20;113(3):415-22.

7.

Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.

Horvath LG, Henshall SM, Kench JG, Turner JJ, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL.

Prostate. 2004 May 15;59(3):234-42.

PMID:
15042598
8.

Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.

Horvath LG, Henshall SM, Kench JG, Saunders DN, Lee CS, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL.

Clin Cancer Res. 2004 Jan 15;10(2):615-25.

9.

Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma.

Rasiah KK, Stricker PD, Haynes AM, Delprado W, Turner JJ, Golovsky D, Brenner PC, Kooner R, O'Neill GF, Grygiel JJ, Sutherland RL, Henshall SM.

Cancer. 2003 Dec 15;98(12):2560-5.

10.

Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.

Henshall SM, Afar DE, Rasiah KK, Horvath LG, Gish K, Caras I, Ramakrishnan V, Wong M, Jeffry U, Kench JG, Quinn DI, Turner JJ, Delprado W, Lee CS, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Mack DH, Sutherland RL.

Oncogene. 2003 Sep 4;22(38):6005-12.

PMID:
12955079
11.

Treatment of localized prostate cancer using a combination of high dose rate Iridium-192 brachytherapy and external beam irradiation: initial Australian experience.

Stevens MJ, Stricker PD, Saalfeld J, Brenner PC, Kooner R, O'Neill GF, Duval PJ, Jagavkar RS, Cross P, Martland J.

Australas Radiol. 2003 Jun;47(2):152-60.

PMID:
12780444
12.

Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.

Quinn DI, Henshall SM, Brenner PC, Kooner R, Golovsky D, O'Neill GF, Turner JJ, Delprado W, Grygiel JJ, Sutherland RL, Stricker PD.

Cancer. 2003 Apr 15;97(8):1884-93.

13.

Prognostic significance of pathologic features in localized prostate cancer treated with radical prostatectomy: implications for staging systems and predictive models.

Quinn DI, Henshall SM, Haynes AM, Brenner PC, Kooner R, Golovsky D, Mathews J, O'Neill GF, Turner JJ, Delprado W, Finlayson JF, Sutherland RL, Grygiel JJ, Stricker PD.

J Clin Oncol. 2001 Aug 15;19(16):3692-705.

PMID:
11504751
14.

Frequent loss of estrogen receptor-beta expression in prostate cancer.

Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL.

Cancer Res. 2001 Jul 15;61(14):5331-5.

15.

Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients.

Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, Delprado W, Stricker PD, Grygiel JJ, Sutherland RL.

Clin Cancer Res. 2001 Mar;7(3):544-50.

16.

Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.

Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, Delprado W, Stricker PD, Grygiel JJ, Sutherland RL.

Cancer Res. 2001 Jan 15;61(2):423-7.

17.

Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy.

Quinn DI, Henshall SM, Head DR, Golovsky D, Wilson JD, Brenner PC, Turner JJ, Delprado W, Finlayson JF, Stricker PD, Grygiel JJ, Sutherland RL.

Cancer Res. 2000 Mar 15;60(6):1585-94.

18.

Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.

Brenner PC, Herr HW, Morse MJ, Sheinfeld J, Aprikian A, Bosl GJ, Motzer RJ, Bajorin DF, Schantz S, Fair WR, Burt M.

J Clin Oncol. 1996 Jun;14(6):1765-9.

PMID:
8656244
19.

TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49.

Brenner PC, Rettig WJ, Sanz-Moncasi MP, Reuter V, Aprikian A, Old LJ, Fair WR, Garin-Chesa P.

J Urol. 1995 May;153(5):1575-9.

PMID:
7536270
20.

Salvage radical prostatectomy in the management of locally recurrent prostate cancer after 125I implantation.

Brenner PC, Russo P, Wood DP, Morse MJ, Donat SM, Fair WR.

Br J Urol. 1995 Jan;75(1):44-7.

PMID:
7850294

Supplemental Content

Loading ...
Support Center